Open Access
E3S Web Conf.
Volume 308, 2021
2021 6th International Conference on Materials Science, Energy Technology and Environmental Engineering (MSETEE 2021)
Article Number 02022
Number of page(s) 5
Section Environmental Ecology and Biochemical Testing
Published online 27 September 2021
  1. Weigelt B, Geyer FC, Reis-Filho JS. Histological types of breast cancer: how special are they? Mol Oncol. 2010 Jun; 4(3):192–208. [Google Scholar]
  2. Dobrolecki LE, Airhart SD, Alferez DG, Aparicio S, Behbod F, Bentires-Alj M, Brisken C, Bult CJ, Cai S, Clarke RB, Dowst H, Ellis MJ, Gonzalez-Suarez E, Iggo RD, Kabos P, Li S, Lindeman GJ, Marangoni E, McCoy A, Meric-Bernstam F, Piwnica-Worms H, Poupon MF, Reis-Filho J, Sartorius CA, Scabia V, Sflomos G, Tu Y, Vaillant F, Visvader JE, Welm A, Wicha MS, Lewis MT. Patient-derived xenograft (PDX) models in basic and translational breast cancer research. Cancer Metastasis Rev. 2016 Dec; 35(4):547–573. [CrossRef] [PubMed] [Google Scholar]
  3. Su, Y., Zheng, Y., Zheng, W., Gu, K., Chen, Z., Li, G., Cai, Q., Lu, W., & Shu, X. O. (2011). Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC cancer, 11, 292. [CrossRef] [PubMed] [Google Scholar]
  4. Rahman SA, Al-Marzouki A, Otim M, Khalil Khayat NEH, Yousuf R, Rahman P. Awareness about Breast Cancer and Breast Self-Examination among Female Students at the University of Sharjah: A Cross-Sectional Study. Asian Pac J Cancer Prev. 2019 Jun 1; 20(6):1901–1908. [CrossRef] [PubMed] [Google Scholar]
  5. Feeney, L. R., Tormey, S. M., & Harmon, D. C. (2018). Breast cancer and chronic pain: a mixed methods review. Irish journal of medical science, 187(4), 877–885. [CrossRef] [PubMed] [Google Scholar]
  6. Mary Ann Kosir, MD, Wayne State University School of Medicine, Breast Cancer, Sep 2020 [Google Scholar]
  7. Nathanson, S. D., Krag, D., Kuerer, H. M., Newman, L. A., Brown, M., Kerjaschki, D., Pereira, E. R., & Padera, T. P. (2018). Breast cancer metastasis through the lympho-vascular system. Clinical & experimental metastasis, 35(5-6), 443–454. [CrossRef] [PubMed] [Google Scholar]
  8. Venkitaraman A. R. (2019). How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?. DNA repair, 81, 102668. [CrossRef] [PubMed] [Google Scholar]
  9. Mahdavi, M., Nassiri, M., Kooshyar, M. M., Vakili-Azghandi, M., Avan, A., Sandry, R., Pillai, S., Lam, A. K., & Gopalan, V. (2019). Hereditary breast cancer; Genetic penetrance and current status with BRCA. Journal of cellular physiology, 234(5), 5741–5750. [CrossRef] [PubMed] [Google Scholar]
  10. Kotsopoulos J. (2018). BRCA Mutations and Breast Cancer Prevention. Cancers, 10(12), 524. [Google Scholar]
  11. Lee A, Moon BI, Kim TH. BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies. Ann Lab Med. 2020 Mar; 40(2):114–121. [CrossRef] [PubMed] [Google Scholar]
  12. Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP. Risk Factors and Preventions of Breast Cancer. Int J Biol Sci. 2017 Nov 1; 13(11):1387–1397. [CrossRef] [PubMed] [Google Scholar]
  13. Coughlin S. S. (2019). Social determinants of breast cancer risk, stage, and survival. Breast cancer research and treatment, 177(3), 537–548. [CrossRef] [PubMed] [Google Scholar]
  14. Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017 Oct 2; 50(1):33. [CrossRef] [PubMed] [Google Scholar]
  15. Jhan JR, Andrechek ER. Triple-negative breast cancer and the potential for targeted therapy. Pharmacogenomics. 2017 Nov; 18(17):1595–1609. [CrossRef] [PubMed] [Google Scholar]
  16. Jafari, S. H., Saadatpour, Z., Salmaninejad, A., Momeni, F., Mokhtari, M., Nahand, J. S., Rahmati, M., Mirzaei, H., & Kianmehr, M. (2018). Breast cancer diagnosis: Imaging techniques and biochemical markers. Journal of cellular physiology, 233(7), 5200–5213. [CrossRef] [PubMed] [Google Scholar]
  17. Valdora, F., Houssami, N., Rossi, F., Calabrese, M., & Tagliafico, A. S. (2018). Rapid review: radiomics and breast cancer. Breast cancer research and treatment, 169(2), 217–229. [CrossRef] [PubMed] [Google Scholar]
  18. Alimirzaie, S., Bagherzadeh, M., & Akbari, M. R. (2019). Liquid biopsy in breast cancer: A comprehensive review. Clinical genetics, 95(6), 643–660. [CrossRef] [PubMed] [Google Scholar]
  19. Li J. (2019). Diagnosis and Treatment of 75 Patients with Idiopathic Lobular Granulomatous Mastitis. Journal of investigative surgery: the official journal of the Academy of Surgical Research, 32(5), 414–420. [Google Scholar]
  20. Tosello, G., Torloni, M. R., Mota, B. S., Neeman, T., & Riera, R. (2018). Breast surgery for metastatic breast cancer. The Cochrane database of systematic reviews, 3(3), CD011276. [PubMed] [Google Scholar]
  21. Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., Manson, J. E., Stefanick, M. L., Pan, K., Barrington, W., Kuller, L. H., Simon, M. S., Lane, D., Johnson, K. C., Rohan, T. E., Gass, M., Cauley, J. A., Paskett, E. D., Sattari, M., & Prentice, R. L. (2020). Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA, 324(4), 369–380. [CrossRef] [PubMed] [Google Scholar]
  22. Spring, L. M., Zangardi, M. L., Moy, B., & Bardia, A. (2017). Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. The oncologist, 22(9), 1039–1048. [CrossRef] [PubMed] [Google Scholar]
  23. Bauersfeld, S. P., Kessler, C. S., Wischnewsky, M., Jaensch, A., Steckhan, N., Stange, R., Kunz, B., Brückner, B., Sehouli, J., & Michalsen, A. (2018). The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC cancer, 18(1), 476. [CrossRef] [PubMed] [Google Scholar]
  24. Gu, G., Dustin, D., & Fuqua, S. A. (2016). Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment. Current opinion in pharmacology, 31, 97–103. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.